The United States amniotic membrane market is expected to register a CAGR of 7.16% during the forecast period, 2022-2028, reaching a revenue share of $880.21 million by 2028.

The market growth is accredited to the rising investments in amniotic membranes and the increasing implementation of amniotic membranes in medical science. At the same time, the market growth is hampered by the costly surgeries and treatments, with fewer insurance facilities that cover costs.

To know more about this report, request a free sample copy

Amniotic membrane (AM) is the innermost fetal layer that lines the amniotic cavity and protects the fetus during pregnancy. The chorionic membrane, i.e., the outer layer, separates the fetus from maternal tissues.

Also, there has been increased research on the physiological functions of fetal layers. Such developments project that the amniotic membrane offers physical support for the fetus. In addition, AM’s anti-scarring, anti-inflammatory, avascular, low immunogenic, wound healing, and translucent properties enable its varied regenerative medicine applications.

One of AM’s earliest applications is in skin burn treatment. This played a substantial role in advancing the amniotic membrane use in surgery in areas like conjunctival and corneal surfaces, skin transplantation, and wounds and open ulcers treatment.

Furthermore, glycerol preservation, cryo-preservation, lyophilization, air-drying, and irradiation techniques extend AM’s shelf life. Besides, these are set to increase the use of AM in ophthalmology for treating limbal, corneal and conjunctival lesions, defects, scars, and burns and reconstruction surgeries of the genitourinary tract, skin, and other surfaces.

In the United States, healthcare service providers are raising awareness about AM for minimizing the suffering from third-degree chronic burn wounds. Additionally, stem cell-based amniotic membranes are estimated to witness high growth during the forecast period.

The segmentation analysis of the United States amniotic membrane market includes end-users, application, and product.The product segment is further sub-segmented into lyophilization amniotic membrane and cryopreserved amniotic membrane. Cryopreserved amniotic membrane has high adoption rates worldwide due to its high efficiency. It is conventionally stored in a cell culture medium with 50% glycerol at -80°C.

Also, AM is well-preserved in cryopreserved AM with biological and histological properties. These membranes are mostly used in visual surgeries that aid in enhanced recovery and reduced eye inflammation.

Further, lyophilization is a preservative method that uses the drying by freezing process to sustain AM at room temperature for longer durations. It is mounted on blue paper. It is also known as a sterilized, freeze-dried amniotic membrane.

As per clinical research, LAM (lyophilized amniotic membrane) is also a good method to preserve human AM for use in ocular surface reconstruction. Further, this method enhances AM use and decreases preservation costs, thereby enabling its transport and storage. Moreover, it maintains the advantageous properties of ocular bandages and offers enhanced biocompatibility.

Some of the eminent firms in the market are Amino Technology Llc, Stryker Corporation, Bio-Tissue Inc, Katena Products Inc, etc.

Stryker Corporation is a leading player in the medical technology industry. It operates through various segments for services and products in the medical sectors like neurotechnology & spine, medical & surgical, and orthopedics. Also, it is a top provider of surgical technology in the global market. Additionally, it is among the top five leading players operating in the neurovascular devices market.

AlloWraps DS is a dual-layer amniotic membrane featuring 2 layers of the amniotic issue and outward-facing epithelial layers. Its processing facilitates Omni-directional implantation.

Report Synopsis

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.